Delivery Order SPE2DB22D1106-SPE2DB25FECD0

Award Date 3/7/25
Potential Completion Date 3/10/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,572.66, is for the delivery of Wegovy 1 mg/0.5 mL pens. It is a firm-fixed-price delivery order contract with a completion date of January 30, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,866.50, is for the delivery of the medication Wegovy 0.5 mg/0.5 ml pen 0.5 ml. It is a firm fixed-price delivery order contract with a period of performance through March 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $16,168.80, is for the delivery of the drug Wegovy 1.7 mg/0.75 ml pen 0.75 ml. It is a firm fixed-price delivery order contract with a completion date of May 15, 2024. This contract award is not designated as a set-aside. AmerisourceBergen holds a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,374.92 firm-fixed-price delivery order is for the supply of Wegovy 1.7 mg/0.75 ml pens with a completion date of September 19, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,022.27 firm fixed-price delivery order is for the supply of Wegovy 0.25 mg/0.5 ml pens. The contract has an ultimate completion date of November 14, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,436.25, is for the delivery of Wegovy 1 mg/0.5 ml pens. It is a firm fixed-price delivery order contract with a completion date of February 7, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,742.70 firm fixed-price delivery order is for the supply of Wegovy 0.5 mg/0.5 ml pens. The contract has a completion date of May 30, 2024. This award is a standalone delivery order and does not indicate a set-aside requirement. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,817.64, is for the delivery of the drug Wegovy 1.7 mg/0.75 ml pen 0.75ml. This is a Firm Fixed Price delivery order contract with a period of performance ending on March 3, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,620.60, is for the delivery of Wegovy 2.4 mg/0.75 ml pens. It is a firm fixed-price delivery order contract with a completion date of February 5, 2025. The contract is not set aside for any specific business type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $29,484.00 firm fixed price delivery order is for the supply of Wegovy 0.25 mg/0.5 ml pens. The award has an ultimate completion date of December 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FECD0
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,711.92, is for the delivery of Wegovy 1.7 mg/0.75 ml pens. This is a firm fixed-price delivery order contract with a completion date of March 10, 2025. The contract is not designated as a set-aside.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 6/6/25, 10:02 AM